Harbour BioMed Secures China’s NMPA Approval for Batoclimab, Expanding Treatment Options for Myasthenia Gravis ...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, shared the first data from a ...
Through its collaboration with OASES and partners across the healthcare ecosystem, Johnson & Johnson looks forward to: ...
Coreline Soft has received U.S. Food and Drug Administration (FDA) 510 (k) clearance for AVIEW Aorta Metrics, its AI-powered ...
Nine markets, six questions, one page to pin above the desk. From Japan's 50,000-patient line to China's brand-new seven-year exclusivity, this is what a rare disease developer actually gets across ...
GIM-621 is a preclinical-stage first-in-class oral small molecule immunotherapy with potential application across multiple ...
Lunit Inc. (KRX: 328130) and Summit Therapeutics Inc. announced a research agreement to evaluate the use of Lunit SCOPE IO, ...
Tairex, an AI healthcare technology company incubated by the Institute for AI Industry Research (AIR) at Tsinghua University, ...
Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
New CAS Connections integration combines over 150 years of curated scientific knowledge with CAS Newton’s agentic AI ...
Median 234 days from first CRO contact to site activation, range 74 to 657; median ethics approval 48 days, median governance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results